On May 3, China Agritech successfully defeated a motion for class certification in a shareholder action filed in the U.S. This is the first court order denying class certification in a proposed securities class action against a China-based U.S.-listed company.

“Defeating a motion for class certification is very rarely accomplished in the U.S. courts,” says Bingna Guo, a Beijing-based O’Melveny & Myers partner who was part of the team that assisted China Agritech on its victory. “Instead of facing the challenges of potentially thousands of plaintiffs, China Agritech is now only facing challenges from four individual plaintiffs.”

She notes now the potential remedies the plaintiffs can ask for is substantially reduced and its client now faces a much more simplified case.

China Agritech’s legal team, which was led by O’Melveny partners Guo, Los Angeles-based Seth Aronson and New York-based Abby Ruzdin, persuaded the court that the plaintiffs were not entitled to class certification because they failed to prove that China Agritech’s stock traded in an efficient market – which is a prerequisite for maintaining a securities fraud class action for damages.

Guo says that with the recent heightened scrutiny by the U.S. securities regulator on China-based U.S.-listed companies, “this case shows that fighting against class certification is a tactic that Chinese companies facing securities litigations need to seriously consider.”

China Agritech was sued in February 2011 by Theodore Dean and other shareholders (the plaintiffs), alleging violations of several provisions in U.S. securities laws.

The plaintiffs’ attempt to certify the class to proceed with the lawsuit as a class action was defeated. The court denied their class certification for failure to prove that the stock traded in an efficient market, which is essential to invoke the fraud on the market presumption. ALB

Candice Mak is North Asia Editor at ALB. Follow her on Twitter: @ALB_Magazine.

Other related stories:

Related Articles

通商、竞天公诚、君合等领衔助力第四范式、十月稻田香港上市(ZH/EN)

近日,香港资本市场迎来多宗重要上市项目,其中AI公司第四范式于国庆假期前登陆港交所,募资约1.07亿美元;食品品牌十月稻田则在假期后完成上市,募资约1.05亿美元。

君合、通商助力AI独角兽第四范式申请赴港上市(ZH/EN)

by Kristen Liu 刘诗宇 |

第四范式智能技术股份有限公司近日向港交所递交招股书,拟赴港上市。君合律师事务所、达维律师事务所为其提供法律意见;通商律师事务所、美迈斯律师事务所则担任联席保荐人律师。

锦天城、植德、通商等助力康诺亚生物港交所上市(ZH/EN)

by Kristen Liu 刘诗宇 |

康诺亚生物近日在香港联交所上市,募集资金约4亿美元。锦天城律师事务所、植德律师事务所、美迈斯律师事务所、蔡余李律师事务所与科律香港律师事务所联盟、科律律师事务所担任发行人律师;通商律师事务所、凯易律师事务所则为联席保荐人提供法律意见。